Annual Total Debt
$9.16 M
-$1.36 M-12.96%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual total debt is $9.16 million, with the most recent change of -$1.36 million (-12.96%) on December 31, 2023.
- During the last 3 years, NRXP annual total debt has risen by +$8.36 million (+1049.44%).
- NRXP annual total debt is now -12.96% below its all-time high of $10.53 million, reached on December 31, 2022.
Performance
NRXP Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$6.67 M
-$982.00 K-12.83%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly total debt is $6.67 million, with the most recent change of -$982.00 thousand (-12.83%) on September 30, 2024.
- Over the past year, NRXP quarterly total debt has dropped by -$110.00 thousand (-1.62%).
- NRXP quarterly total debt is now -47.46% below its all-time high of $12.69 million, reached on June 30, 2023.
Performance
NRXP Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
NRXP Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.0% | -1.6% |
| 3 y3 years | +1049.4% | +100.0% |
| 5 y5 years | +1049.4% | +100.0% |
NRXP Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.0% | +1668.5% | -47.5% | -100.0% |
| 5 y | 5-year | -13.0% | +1668.5% | -47.5% | -100.0% |
| alltime | all time | -13.0% | +1668.5% | -47.5% | -100.0% |
NRx Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.67 M(-12.8%) |
| Jun 2024 | - | $7.65 M(+12.9%) |
| Mar 2024 | - | $6.78 M(-26.0%) |
| Dec 2023 | $9.16 M(-13.0%) | $9.16 M(-9.0%) |
| Sep 2023 | - | $10.07 M(-20.7%) |
| Jun 2023 | - | $12.69 M(+4.1%) |
| Mar 2023 | - | $12.19 M(+15.8%) |
| Dec 2022 | $10.53 M | $10.53 M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $0.00(-100.0%) |
| Mar 2022 | - | $520.00 K(+0.4%) |
| Dec 2021 | $518.00 K(-35.0%) | $518.00 K(+0.6%) |
| Sep 2021 | - | $515.10 K(-24.9%) |
| Jun 2021 | - | $686.20 K(>+9900.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $797.00 K | $797.00 K(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00 |
FAQ
- What is NRx Pharmaceuticals annual total debt?
- What is the all time high annual total debt for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual total debt year-on-year change?
- What is NRx Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly total debt year-on-year change?
What is NRx Pharmaceuticals annual total debt?
The current annual total debt of NRXP is $9.16 M
What is the all time high annual total debt for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total debt is $10.53 M
What is NRx Pharmaceuticals annual total debt year-on-year change?
Over the past year, NRXP annual total debt has changed by -$1.36 M (-12.96%)
What is NRx Pharmaceuticals quarterly total debt?
The current quarterly total debt of NRXP is $6.67 M
What is the all time high quarterly total debt for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total debt is $12.69 M
What is NRx Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, NRXP quarterly total debt has changed by -$110.00 K (-1.62%)